Last reviewed · How we verify
Rhabdomyosarcoma
Approved treatments
- Oncovin · University of Colorado, Denver
- Vincristin · Arbeitsgemeinschaft medikamentoese Tumortherapie
- Oncovin · Pfizer Inc.
- Oncovin · Pfizer Inc.
- Cosmegen · Recordati
Dactinomycin binds DNA and inhibits RNA synthesis, demonstrating cytotoxic activity in cancer models.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Rhabdomyosarcoma patent landscape — cliff calendar, originator estates, attackable patents
- Rhabdomyosarcoma treatment landscape brief
- Rhabdomyosarcoma treatment updates RSS
Frequently asked questions about Rhabdomyosarcoma
What drugs treat Rhabdomyosarcoma?
Tracked treatments include Oncovin, Vincristin, Cosmegen.
What is the treatment for Rhabdomyosarcoma?
Standard treatment for Rhabdomyosarcoma includes Oncovin, Vincristin, Cosmegen. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Rhabdomyosarcoma patent cliff · Rhabdomyosarcoma CI report
- Treatment: Oncovin · University of Colorado, Denver
- Treatment: Vincristin · Arbeitsgemeinschaft medikamentoese Tumortherapie
- Treatment: Oncovin · Pfizer Inc.
- Treatment: Oncovin · Pfizer Inc.
- Treatment: Cosmegen · Recordati
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing